Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 19/20 | 0.54 |
| ▸ | LY96 | Q9Y6Y9 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8603738 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL8435689 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL8521876 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL6803469 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL8598586 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL8522202 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL8522205 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL8521519 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL8521023 | 1.00 | TLR4 (0.54) | TLR4LY96 | |
| SCHEMBL8521873 | 1.00 | TLR4 (0.54) | TLR4LY96 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1031351-B1 | LEISHMANIASIS REMEDY CONTAINING GLUCOPYRANOSE DERIVATIVE AS THE ACTIVE INGREDIENT | UNIV THE RYUKYU (JP) | 2005-01-05 | — | — | EP | claimed |
| EP-1031351-B1 | LEISHMANIASIS REMEDY CONTAINING GLUCOPYRANOSE DERIVATIVE AS THE ACTIVE INGREDIENT | UNIV THE RYUKYU (JP) | 2005-01-05 | — | — | EP | disclosed |
| US-6444648-B1 | PREVENTING AND/OR TREATING DISEASE CAUSED BY LEISHMANIASIS INFECTIOUS SPECIES | UNIVERSITY OF THE RYUKYU (JP) | 2002-09-03 | — | — | US | disclosed |
| US-6444648-B1 | PREVENTING AND/OR TREATING DISEASE CAUSED BY LEISHMANIASIS INFECTIOUS SPECIES | UNIVERSITY OF THE RYUKYU (JP) | 2002-09-03 | — | — | US | disclosed |
| EP-1031351-A1 | LEISHMANIASIS REMEDY CONTAINING GLUCOPYRANOSE DERIVATIVE AS THE ACTIVE INGREDIENT | University of the Ryukyu (JP) | 2000-08-30 | — | — | EP | disclosed |
| JP-2000063396-A | THERAPEUTIC AGENT FOR LEISHMANIASIS COMPRISING GLUCOPYRANOSE DERIVATIVE AS ACTIVE INGREDIENT | UNIV OF THE RYUKYUS | 2000-02-29 | — | — | JP | disclosed |